4.5 Article

Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF, receptor antagonist antalarmin and by CRF, receptor knockout

Journal

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
Volume 86, Issue 4, Pages 813-821

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.pbb.2007.03.009

Keywords

mouse; dependence; abstinence; ethanol self-administration; corticotropin-releasing factor; CRF1

Funding

  1. NIAAA NIH HHS [U01 AA013482, U01 AA013523-05, U01 AA013523, U01 AA013482-05, AA13523, AA13482] Funding Source: Medline

Ask authors/readers for more resources

Models of dependence-induced increases in ethanol self-administration will be critical in increasing our understanding of the processes of addiction and relapse, underlying mechanisms, and potential therapeutics. One system that has received considerable attention recently is the CRF1 system that may mediate the link between anxiety states and relapse drinking. C57BL/6J mice were trained to lever press for ethanol, were made dependent and then were allowed to self-administer ethanol following a period of abstinence. The effect of the CRF1 antagonist, antalarmin, was examined on this abstinence-induced self-administration in a separate group of mice. Finally, dependence-induced changes in ethanol self-administration were examined in CRF1 knockout and wild type mice. The results indicated that ethanol self-administration was increased following the induction of dependence, but only after a period of abstinence. This increase in ethanol self-administration was blocked by antalarmin. Furthermore, CRF1 knockout mice did not display this increased ethanol self-administration following dependence and abstinence. These studies, using both a pharmacological and genetic approach, support a critical role for the CRF1 system in ethanol self-administration following dependence. In addition, a model is presented that may be useful for studies examining underlying mechanisms of the ethanol addiction process as well as for testing potential therapeutics. (c) 2007 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available